ERC-ESICM guidelines on temperature control after cardiac arrest in adults.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
03 2022
Historique:
received: 07 01 2022
accepted: 11 01 2022
pubmed: 9 2 2022
medline: 26 3 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

The aim of these guidelines is to provide evidence‑based guidance for temperature control in adults who are comatose after resuscitation from either in-hospital or out-of-hospital cardiac arrest, regardless of the underlying cardiac rhythm. These guidelines replace the recommendations on temperature management after cardiac arrest included in the 2021 post-resuscitation care guidelines co-issued by the European Resuscitation Council (ERC) and the European Society of Intensive Care Medicine (ESICM). The guideline panel included thirteen international clinical experts who authored the 2021 ERC-ESICM guidelines and two methodologists who participated in the evidence review completed on behalf of the International Liaison Committee on Resuscitation (ILCOR) of whom ERC is a member society. We followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of evidence and grade recommendations. The panel provided suggestions on guideline implementation and identified priorities for future research. The certainty of evidence ranged from moderate to low. In patients who remain comatose after cardiac arrest, we recommend continuous monitoring of core temperature and actively preventing fever (defined as a temperature > 37.7 °C) for at least 72 hours. There was insufficient evidence to recommend for or against temperature control at 32-36 °C or early cooling after cardiac arrest. We recommend not actively rewarming comatose patients with mild hypothermia after return of spontaneous circulation (ROSC) to achieve normothermia. We recommend not using prehospital cooling with rapid infusion of large volumes of cold intravenous fluids immediately after ROSC.

Identifiants

pubmed: 35131119
pii: S0300-9572(22)00010-7
doi: 10.1016/j.resuscitation.2022.01.009
pii:
doi:

Types de publication

Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

229-236

Informations de copyright

Copyright © 2022 European Resuscitation Council. Published by Elsevier B.V. All rights reserved.

Auteurs

Jerry P Nolan (JP)

University of Warwick, Warwick Medical School, Coventry CV4 7AL, UK; Department of Anaesthesia and Intensive Care Medicine, Royal United Hospital, Bath BA1 3NG, UK. Electronic address: jerry.nolan@nhs.net.

Claudio Sandroni (C)

Department of Emergency Medicine and Anaesthesiology, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy; Institute of Anaesthesiology and Intensive Care Medicine, Università Cattolica del Sacro Cuore, Rome, Italy.

Lars W Andersen (LW)

Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark; Research Center for Emergency Medicine, Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark; Prehospital Emergency Medical Services, Central Denmark Region, Denmark.

Bernd W Böttiger (BW)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Anaesthesiology and Intensive Care Medicine, Germany.

Alain Cariou (A)

Cochin University Hospital (APHP) and University of Paris (Medical School), Paris, France.

Tobias Cronberg (T)

Department of Clinical Sciences, Neurology, Lund University, Skane University Hospital, Lund, Sweden.

Hans Friberg (H)

Department of Clinical Sciences, Anaesthesia and Intensive Care Medicine, Lund University, Skane University Hospital, Malmö, Sweden.

Cornelia Genbrugge (C)

Acute Medicine Research Pole, Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain, Brussels, Belgium; Emergency Department, University Hospitals Saint-Luc, Brussels, Belgium.

Gisela Lilja (G)

Department of Clinical Sciences, Neurology, Lund University, Skane University Hospital, Lund, Sweden.

Peter T Morley (PT)

University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia.

Nikolaos Nikolaou (N)

Cardiology Department, Konstantopouleio General Hospital, Athens, Greece.

Theresa M Olasveengen (TM)

Department of Anesthesiology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Markus B Skrifvars (MB)

Department of Emergency Care and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Fabio S Taccone (FS)

Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Jasmeet Soar (J)

Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH